The global race to develop so-called “double G” and “triple G” agonists is heating up to boost the efficacy of…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
October 22, 2014
-
REGULATORY Health Ministry Eyes Future Genomic Data Registration at National Medical Centers
October 21, 2014
-
BUSINESS Astellas to End License Agreement with US Venture Company for AD Treatments
October 20, 2014
-
BUSINESS Bayer AG Aims to Achieve Japan Sales of 300 Billion Yen by 2017
October 17, 2014
-
REGULATORY NIBIO to Begin Drug Seed Optimization Project from FY2015
October 16, 2014
-
REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
October 15, 2014
-
BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
October 14, 2014
-
ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
-
BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
October 10, 2014
-
REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
October 9, 2014
-
BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
October 8, 2014
-
BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
October 7, 2014
-
BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
-
BUSINESS MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
October 2, 2014
-
BUSINESS Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
October 2, 2014
-
BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
October 1, 2014
-
BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz
September 30, 2014
-
BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm
September 29, 2014
-
ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
ページ
1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…